Screening Data definition

Screening Data shall have the meaning set forth in Section 7.3.
Sample 1Sample 2Sample 3
Screening Data means all data arising from the Screening Activities;
Sample 1Sample 2
Screening Data shall have the meaning specified in Section 4.4.
Sample 1Sample 2

Examples of Screening Data in a sentence

  • Each party recognizes the mutual interest in avoiding premature publication of information and data with respect to the results of the Screening Program ("Screening Data").

  • Neurocrine shall pay to Caliper the following amounts within thirty (30) days of receiving an invoice from Caliper, which will be delivered concurrent with delivery of the Screening Data: [ * ]/Data Point for the [ * ] LabChip Assays or [ * ], whichever comes first.

  • Subject to Sections 4.1 and 4.2, Lilly shall own all information and data resulting from or arising out of its Screening activities (collectively, "Screening Data") and all discoveries and Lilly Products based on or resulting from such Screening Data.

  • Neurocrine and Caliper are each free to work with any other company in any area, provided that the Screening Data is used by each company in accordance with Article 3 below and each party complies with the other terms of this Agreement, including but not limited to Section 2.5(c).

  • In the event this Agreement is terminated by either party before Screening Data is delivered for the [ * ] LabChip Assay, the parties shall negotiate in good faith the terms and conditions under which Caliper may retain a portion of the Neurocrine Compounds.

  • Following the Target Validation Studies with respect to a Target, the JRDC will deliver the results and data from the Screening Data Analysis and Target Validation Studies for such Target to the JSC for further evaluation.

  • The parties recognize that Caliper's use or disclosure of the Screening Data could [ * ], and Caliper acknowledges that Neurocrine may [ * ], and in no event shall Neurocrine be required to [ * ].

  • Subject to the foregoing, after a Party exercises its right to opt out with respect to a Collaboration Target, such opt-out Party shall have the right, either alone or via an Affiliate or partnering with a third party, to develop programs and exploit products and compounds directed to such Target outside the Collaboration provided that (a) such Party does not use the Collaboration Screening Data to initiate or conduct such programs, and (b) [***].

  • For clarity, neither Party shall, nor shall either Party be required to, contribute to the Collaboration any Screening Data not related to Respiratory Viral Diseases.

  • INTRABIOTICS shall own all Screening Data and all intellectual property rights related thereto.


More Definitions of Screening Data

Screening Data means a summary report prepared by Tularik for each JT Assay describing: [ * ].
Sample 1Sample 2
Screening Data means all Data Points delivered to Neurocrine pursuant to instructions from the Screening Committee, as described in Section 2.6(b).
Sample 1Sample 2
Screening Data means the data resulting or derived from the screening of the libraries by INTRABIOTICS, including but not limited to the data describing the specific Activity of each of the samples of interest to INTRABIOTICS, including [ * ]. 1.26 “Screening Field” means the identification of compounds having anti-bacterial or anti-fungal properties.
Sample 1
Screening Data means data, know-how and information resulting from Respiratory Viral Functional Genomic Screens, including any analysis thereof.
Sample 1

Related to Screening Data

  • Dataset means the data specified in Appendix 1 (Environmental Information) to Schedule 11.2 (Management Information) as the same may be amended from time to time by the Secretary of State (acting reasonably);

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Sample means urine, blood, breath, saliva, or hair.

  • Study Data shall have the meaning set forth in Section 8.1.

  • System Data means data and data elements collected by the SaaS Software, SaaS Service or Licensor’s computer systems regarding configuration, environment, usage, performance, vulnerabilities and security of the SaaS Software or SaaS Service that may be used to generate logs, statistics and reports regarding performance, availability, integrity and security of the SaaS Software.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Peer-reviewed medical literature means a published scientific study in a journal or other publication in which original manuscripts have been published only after having been critically reviewed for scientific accuracy, validity and reliability by unbiased independent experts, and that has been determined by the international committee of medical journal editors to have met the uniform requirements for manuscripts submitted to biomedical journals. Peer-reviewed medical literature does not include publications or supplements to publications that are sponsored to a significant extent by a pharmaceutical manufacturing company or health carrier.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing and control data, preclinical data, clinical data and all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product (including any applicable Drug Master Files (“DMFs”), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Regulatory Information Service means a regulatory information service as defined in the FCA Handbook;

  • Samples mean representative physical examples of materials, equipment or workmanship, used to confirm compliance with requirements and/or to establish standards for use in execution of the Work.

  • Patient Data means any electronic data, information or material about a Patient entered into the Software.

  • Clinical Data means the information with respect to the Licensed Product or the Licensed Compound made, collected or otherwise generated under or in connection with pre-clinical, clinical, or the post-Approval studies for the Licensed Compound or Licensed Product, including any data, reports and results with respect to any of the foregoing.

  • Research Data means documents in a digital form, other than scientific publications, which are collected or produced in the course of scientific research activities and are used as evidence in the research process, or are commonly accepted in the research community as necessary to validate research findings and results;

  • Studies means activities needed to prepare project implementation, such as preparatory, mapping, feasibility, evaluation, testing and validation studies, including in the form of software, and any other technical support measure, including prior action to define and develop a project and decide on its financing, such as reconnaissance of the sites concerned and preparation of the financial package;

  • Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams, and other information furnished by the Contractor to illustrate materials or equipment for some portion of the Work.

  • Data means recorded information, regardless of form, the media on which it is recorded, or the method of recording.

  • Health data means data related to the state of physical or mental health of the data principal and includes records regarding the past, present or future state of the health of such data principal, data collected in the course of registration for, or provision of health services, data associating the data principal to the provision of specific health services.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.